Simple Congenital Heart Diseases Tied to Higher Epilepsy Risk

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Feb. 11, 2025 -- Among simple congenital heart diseases (CHD), patent foramen ovale (PFO) is associated with a significantly higher risk for epilepsy, according to a study published in the February issue of CNS Neuroscience & Therapeutics.

Lei Chen, M.D., Ph.D., from Sichuan University in Chengdu, China, and colleagues compared the risk for epilepsy in patients with different types of simple CHD. The analysis included 10,914 patients born (January 2008 to June 2022) with atrial septal defect (ASD), PFO, ventricular septal defect (VSD), and patent ductus arteriosus (PDA).

The researchers found that 108 individuals were diagnosed with epilepsy at an average follow-up of 2.19 years. Epilepsy incidence in patients with PFO, VSD, PDA, and ASD was 8.58, 4.85, 3.98, and 2.63 per 1,000 person-years, respectively. The risk for epilepsy was elevated in patients with PFO, VSD, and PDA (risk ratios [95 percent confidence intervals], 3.28 [2.00 to 5.43], 1.47 [0.79 to 2.68], and 1.46 [0.70 to 2.82], respectively) compared with patients with ASD. Patients with simple CHD who underwent CHD surgery had a lower risk for epilepsy than those who did not undergo surgery.

"These findings have implications for future research on the pathogenesis of PFO and incidence of central nervous system diseases, and perhaps importantly, for the prevention and treatment of epilepsy in patients with PFO," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords